List of Tables
Table 1. Global Neurological Disease Model Chip Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Neurological Disease Model Chip Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Neurological Disease Model Chip Market Competitive Situation by Manufacturers in 2025
Table 4. Global Neurological Disease Model Chip Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Neurological Disease Model Chip Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Neurological Disease Model Chip Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Neurological Disease Model Chip Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Neurological Disease Model Chip Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Neurological Disease Model Chip, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Neurological Disease Model Chip, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Neurological Disease Model Chip, Product Types and Applications
Table 12. Global Key Manufacturers of Neurological Disease Model Chip, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Neurological Disease Model Chip Companies by Tier (Tier 1, Tier 2, Tier 3), based on Neurological Disease Model Chip Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Neurological Disease Model Chip Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Neurological Disease Model Chip Sales by Region (K Units), 2021–2026
Table 18. Global Neurological Disease Model Chip Sales Market Share by Region (2021–2026)
Table 19. Global Neurological Disease Model Chip Sales by Region (K Units), 2027–2032
Table 20. Global Neurological Disease Model Chip Sales Market Share by Region (2027–2032)
Table 21. Global Neurological Disease Model Chip Revenue by Region (US$ Million), 2021–2026
Table 22. Global Neurological Disease Model Chip Revenue Market Share by Region (2021–2026)
Table 23. Global Neurological Disease Model Chip Revenue by Region (US$ Million), 2027–2032
Table 24. Global Neurological Disease Model Chip Revenue Market Share by Region (2027–2032)
Table 25. North America Neurological Disease Model Chip Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Neurological Disease Model Chip Sales by Country (K Units), 2021–2026
Table 27. North America Neurological Disease Model Chip Sales by Country (K Units), 2027–2032
Table 28. North America Neurological Disease Model Chip Revenue by Country (US$ Million), 2021–2026
Table 29. North America Neurological Disease Model Chip Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Neurological Disease Model Chip Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Neurological Disease Model Chip Sales by Country (K Units), 2021–2026
Table 32. Europe Neurological Disease Model Chip Sales by Country (K Units), 2027–2032
Table 33. Europe Neurological Disease Model Chip Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Neurological Disease Model Chip Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Neurological Disease Model Chip Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Neurological Disease Model Chip Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Neurological Disease Model Chip Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Neurological Disease Model Chip Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Neurological Disease Model Chip Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Neurological Disease Model Chip Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Neurological Disease Model Chip Sales by Country (K Units), 2021–2026
Table 42. Latin America Neurological Disease Model Chip Sales by Country (K Units), 2027–2032
Table 43. Latin America Neurological Disease Model Chip Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Neurological Disease Model Chip Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Neurological Disease Model Chip Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Neurological Disease Model Chip Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Neurological Disease Model Chip Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Neurological Disease Model Chip Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Neurological Disease Model Chip Revenue by Country (US$ Million), 2027–2032
Table 50. Global Neurological Disease Model Chip Sales (K Units) by Type (2021–2026)
Table 51. Global Neurological Disease Model Chip Sales (K Units) by Type (2027–2032)
Table 52. Global Neurological Disease Model Chip Sales Market Share by Type (2021–2026)
Table 53. Global Neurological Disease Model Chip Sales Market Share by Type (2027–2032)
Table 54. Global Neurological Disease Model Chip Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Neurological Disease Model Chip Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Neurological Disease Model Chip Revenue Market Share by Type (2021–2026)
Table 57. Global Neurological Disease Model Chip Revenue Market Share by Type (2027–2032)
Table 58. Global Neurological Disease Model Chip Price (US$/Unit) by Type (2021–2026)
Table 59. Global Neurological Disease Model Chip Price (US$/Unit) by Type (2027–2032)
Table 60. Global Neurological Disease Model Chip Sales (K Units) by Application (2021–2026)
Table 61. Global Neurological Disease Model Chip Sales (K Units) by Application (2027–2032)
Table 62. Global Neurological Disease Model Chip Sales Market Share by Application (2021–2026)
Table 63. Global Neurological Disease Model Chip Sales Market Share by Application (2027–2032)
Table 64. Global Neurological Disease Model Chip Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Neurological Disease Model Chip Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Neurological Disease Model Chip Revenue Market Share by Application (2021–2026)
Table 67. Global Neurological Disease Model Chip Revenue Market Share by Application (2027–2032)
Table 68. Global Neurological Disease Model Chip Price (US$/Unit) by Application (2021–2026)
Table 69. Global Neurological Disease Model Chip Price (US$/Unit) by Application (2027–2032)
Table 70. Emulate Company Information
Table 71. Emulate Description and Business Overview
Table 72. Emulate Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Emulate Neurological Disease Model Chip Product
Table 74. Emulate Recent Developments/Updates
Table 75. CN Bio Company Information
Table 76. CN Bio Description and Business Overview
Table 77. CN Bio Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. CN Bio Neurological Disease Model Chip Product
Table 79. CN Bio Recent Developments/Updates
Table 80. TissUse Company Information
Table 81. TissUse Description and Business Overview
Table 82. TissUse Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. TissUse Neurological Disease Model Chip Product
Table 84. TissUse Recent Developments/Updates
Table 85. AxoSim Technologies Company Information
Table 86. AxoSim Technologies Description and Business Overview
Table 87. AxoSim Technologies Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. AxoSim Technologies Neurological Disease Model Chip Product
Table 89. AxoSim Technologies Recent Developments/Updates
Table 90. Nortis Company Information
Table 91. Nortis Description and Business Overview
Table 92. Nortis Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Nortis Neurological Disease Model Chip Product
Table 94. Nortis Recent Developments/Updates
Table 95. Mimetas Company Information
Table 96. Mimetas Description and Business Overview
Table 97. Mimetas Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Mimetas Neurological Disease Model Chip Product
Table 99. Mimetas Recent Developments/Updates
Table 100. SynVivo Company Information
Table 101. SynVivo Description and Business Overview
Table 102. SynVivo Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. SynVivo Neurological Disease Model Chip Product
Table 104. SynVivo Recent Developments/Updates
Table 105. Axion Biosystems Company Information
Table 106. Axion Biosystems Description and Business Overview
Table 107. Axion Biosystems Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Axion Biosystems Neurological Disease Model Chip Product
Table 109. Axion Biosystems Recent Developments/Updates
Table 110. Tara Biosystems Company Information
Table 111. Tara Biosystems Description and Business Overview
Table 112. Tara Biosystems Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Tara Biosystems Neurological Disease Model Chip Product
Table 114. Tara Biosystems Recent Developments/Updates
Table 115. InSphero Company Information
Table 116. InSphero Description and Business Overview
Table 117. InSphero Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. InSphero Neurological Disease Model Chip Product
Table 119. InSphero Recent Developments/Updates
Table 120. Hesperos Company Information
Table 121. Hesperos Description and Business Overview
Table 122. Hesperos Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Hesperos Neurological Disease Model Chip Product
Table 124. Hesperos Recent Developments/Updates
Table 125. Kugelmeiers Company Information
Table 126. Kugelmeiers Description and Business Overview
Table 127. Kugelmeiers Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Kugelmeiers Neurological Disease Model Chip Product
Table 129. Kugelmeiers Recent Developments/Updates
Table 130. Ascendance Biotechnology Company Information
Table 131. Ascendance Biotechnology Description and Business Overview
Table 132. Ascendance Biotechnology Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Ascendance Biotechnology Neurological Disease Model Chip Product
Table 134. Ascendance Biotechnology Recent Developments/Updates
Table 135. BioIVT Company Information
Table 136. BioIVT Description and Business Overview
Table 137. BioIVT Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. BioIVT Neurological Disease Model Chip Product
Table 139. BioIVT Recent Developments/Updates
Table 140. BGI Genomics Company Information
Table 141. BGI Genomics Description and Business Overview
Table 142. BGI Genomics Neurological Disease Model Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. BGI Genomics Neurological Disease Model Chip Product
Table 144. BGI Genomics Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Neurological Disease Model Chip Distributors List
Table 148. Neurological Disease Model Chip Customers List
Table 149. Neurological Disease Model Chip Market Trends
Table 150. Neurological Disease Model Chip Market Drivers
Table 151. Neurological Disease Model Chip Market Challenges
Table 152. Neurological Disease Model Chip Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Neurological Disease Model Chip
Figure 2. Global Neurological Disease Model Chip Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Neurological Disease Model Chip Market Share by Type: 2025 & 2032
Figure 4. Neuron Chip Product Picture
Figure 5. Brain Chip Product Picture
Figure 6. Brain Organ Chip Product Picture
Figure 7. Global Neurological Disease Model Chip Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Neurological Disease Model Chip Market Share by Application: 2025 & 2032
Figure 9. Pharmaceutical R&D
Figure 10. Neuroscience Research
Figure 11. Clinical Diagnosis
Figure 12. Global Neurological Disease Model Chip Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Neurological Disease Model Chip Market Size (US$ Million), 2021–2032
Figure 14. Global Neurological Disease Model Chip Sales (K Units), 2021–2032
Figure 15. Global Neurological Disease Model Chip Average Price (US$/Unit), 2021–2032
Figure 16. Neurological Disease Model Chip Report Years Considered
Figure 17. Neurological Disease Model Chip Sales Share by Manufacturers in 2025
Figure 18. Global Neurological Disease Model Chip Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Neurological Disease Model Chip Players: Market Share by Revenue in Neurological Disease Model Chip in 2025
Figure 20. Neurological Disease Model Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Neurological Disease Model Chip Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Neurological Disease Model Chip Sales Market Share by Country (2021–2032)
Figure 23. North America Neurological Disease Model Chip Revenue Market Share by Country (2021–2032)
Figure 24. United States Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Neurological Disease Model Chip Sales Market Share by Country (2021–2032)
Figure 27. Europe Neurological Disease Model Chip Revenue Market Share by Country (2021–2032)
Figure 28. Germany Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Neurological Disease Model Chip Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Neurological Disease Model Chip Revenue Market Share by Region (2021–2032)
Figure 35. China Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Neurological Disease Model Chip Sales Market Share by Country (2021–2032)
Figure 43. Latin America Neurological Disease Model Chip Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Neurological Disease Model Chip Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Neurological Disease Model Chip Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Neurological Disease Model Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Neurological Disease Model Chip by Type (2021–2032)
Figure 54. Global Revenue Market Share of Neurological Disease Model Chip by Type (2021–2032)
Figure 55. Global Neurological Disease Model Chip Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Neurological Disease Model Chip by Application (2021–2032)
Figure 57. Global Revenue Market Share of Neurological Disease Model Chip by Application (2021–2032)
Figure 58. Global Neurological Disease Model Chip Price (US$/Unit) by Application (2021–2032)
Figure 59. Neurological Disease Model Chip Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
